Published in Neurology on March 11, 2009
Seeing injectable MS therapies differently: they are more similar than different. Neurology (2009) 1.47
Optimizing outcomes in multiple sclerosis: consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America. Ther Adv Neurol Disord (2011) 0.92
Interferon β-1b and glatiramer acetate effects on permanent black hole evolution. Neurology (2011) 0.91
Interferon beta and glatiramer acetate therapy. Neurotherapeutics (2013) 0.90
Treatment strategies for multiple sclerosis: When to start, when to change, when to stop? World J Clin Cases (2015) 0.88
Effect of glatiramer acetate three-times weekly on the evolution of new, active multiple sclerosis lesions into T1-hypointense "black holes": a post hoc magnetic resonance imaging analysis. J Neurol (2014) 0.84
Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment. Patient Prefer Adherence (2014) 0.84
Clinical utility of glatiramer acetate in the management of relapse frequency in multiple sclerosis. J Cent Nerv Syst Dis (2012) 0.84
Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis. Ther Clin Risk Manag (2010) 0.83
Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials. Mult Scler Int (2014) 0.81
Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010. Int J MS Care (2012) 0.79
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis. Neuropsychiatr Dis Treat (2013) 0.79
Managing MS in a changing treatment landscape. J Neurol (2011) 0.79
Current perspectives on interferon Beta-1b for the treatment of multiple sclerosis. Adv Ther (2014) 0.79
Interpreting therapeutic effect in multiple sclerosis via MRI contrast enhancing lesions: now you see them, now you don't. J Neurol (2014) 0.78
Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective? BMC Neurol (2011) 0.78
Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies. Adolesc Health Med Ther (2010) 0.77
Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosis. Ther Adv Neurol Disord (2015) 0.77
MTR recovery in brain lesions in the BECOME study of glatiramer acetate vs interferon β-1b. Neurology (2016) 0.77
Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosis. CNS Drugs (2014) 0.77
Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis. J Inflamm Res (2010) 0.76
Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol. JMIR Res Protoc (2016) 0.76
Effectiveness of glatiramer acetate compared to other multiple sclerosis therapies. Brain Behav (2015) 0.76
Longitudinal changes in self-reported walking ability in multiple sclerosis. PLoS One (2015) 0.75
Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribine. Drug Des Devel Ther (2010) 0.75
Comparison of standard 1.5 T vs. 3 T optimized protocols in patients treated with glatiramer acetate. A serial MRI pilot study. Int J Mol Sci (2012) 0.75
Heterogeneity in longitudinal evolution of ring-enhancing multiple sclerosis lesions. Ann Neurol (2011) 0.75
Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations. Ther Clin Risk Manag (2016) 0.75
Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am (2001) 5.13
Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat Med (1996) 4.57
Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension (2001) 4.07
The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology (1985) 3.55
Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol (2001) 3.49
Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology (1995) 2.90
Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiation. Proc Natl Acad Sci U S A (1977) 2.80
Studies with B-cell allo- and hetero-antisera: parallel reactivity and special properties. Scand J Immunol (1976) 2.74
Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann Intern Med (1983) 2.50
Cellular localization of gene expression for progranulin. J Histochem Cytochem (2000) 2.38
No eye pad for corneal abrasion. Eye (Lond) (1993) 1.85
Effects of bone mineral density on pedicle screw fixation. Spine (Phila Pa 1976) (1994) 1.83
Quantitative functional measures in MS: what is a reliable change? Neurology (2002) 1.81
Patterns of expression of human "Ia-like" antigens during the terminal stages of B cell development. J Immunol (1978) 1.76
Lumbar spine and femoral neck bone mineral density in idiopathic scoliosis: a follow-up study. J Pediatr Orthop (1992) 1.75
Circulating demyelinating factors in acute idiopathic polyneuropathy. Arch Neurol (1971) 1.74
Changes in the monoamine containing neurones of the human CNS in senile dementia. Br J Psychiatry (1980) 1.74
Age-related decline in proprioception. Clin Orthop Relat Res (1984) 1.70
Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med (1993) 1.69
Landry-Guillain-Barré syndrome. A primary demyelinating disease. Arch Neurol (1969) 1.67
Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis. Neurology (1980) 1.62
Declining incidence of multiple sclerosis in the Orkney Islands. Neurology (1985) 1.54
Shortened telomere length in white blood cells of patients with IDDM. Diabetes (1998) 1.52
Severe botulism after focal injection of botulinum toxin. Neurology (2006) 1.51
Acanthamoeba keratitis. Surv Ophthalmol (1998) 1.49
Tendon proteoglycans: biochemistry and function. J Musculoskelet Neuronal Interact (2005) 1.45
Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis. Acta Neurol Scand (1999) 1.44
mTert expression correlates with telomerase activity during the differentiation of murine embryonic stem cells. Mech Dev (2000) 1.43
Combined interrupted and continuous versus single continuous adjustable suturing in penetrating keratoplasty: a prospective, randomized study of induced astigmatism during the first postoperative year. Ophthalmology (1998) 1.43
The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg Am (2001) 1.42
Effect of articular disease and total knee arthroplasty on knee joint-position sense. J Neurophysiol (1983) 1.41
Brain magnetic resonance imaging in adults with asthma. Contemp Clin Trials (2010) 1.41
Human papillomavirus typing in HIV-positive women. Infect Dis Obstet Gynecol (2001) 1.41
Femoral neck and lumbar spine bone mineral densities in a normal population 3-20 years of age. J Pediatr Orthop (1991) 1.40
Synchrony in telomere length of the human fetus. Hum Genet (1998) 1.37
Telomere attrition of the human abdominal aorta: relationships with age and atherosclerosis. Atherosclerosis (2000) 1.37
Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol (1995) 1.36
A survey of running injuries in 1505 competitive and recreational runners. J Sports Med Phys Fitness (1990) 1.35
Detection of latent virus mRNA in tissues using the polymerase chain reaction. J Pathol (1989) 1.33
Effects of lysozyme on normal and transformed mammalian cells. Nature (1973) 1.33
Canine distemper virus L gene: sequence and comparison with related viruses. Virology (1993) 1.30
Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. Proc Natl Acad Sci U S A (1999) 1.27
Sequence variability and function of measles virus 3' and 5' ends and intercistronic regions. Virology (1988) 1.25
Corneal transplantation: how successful are we? Br J Ophthalmol (2000) 1.21
Neurological findings of Lyme disease. Yale J Biol Med (1985) 1.21
Guillain-Barré syndrome in Greater New York-New Jersey. JAMA (1977) 1.20
Trabecular bone mineral density in idiopathic scoliosis. J Pediatr Orthop (1987) 1.19
Ultrastructural localisation of substance P and choline acetyltransferase in endothelial cells of rat coronary artery and release of substance P and acetylcholine during hypoxia. Experientia (1989) 1.19
Meningio-angiomatosis: a report of six cases with special reference to the occurrence of neurofibrillary tangles. J Neuropathol Exp Neurol (1986) 1.18
Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of lyme disease. Lab Invest (2000) 1.18
Joint position sense in total knee arthroplasty. J Orthop Res (1984) 1.16
A biomechanical analysis of the etiology of tibia vara. J Pediatr Orthop (1983) 1.15
Effects of a geriatric clinic on functional health and well-being of elders. J Gerontol (1987) 1.15
Canine distemper terminal and intergenic non-protein coding nucleotide sequences: completion of the entire CDV genome sequence. Virology (1993) 1.14
Leukocytes of exceptionally old persons display ultra-short telomeres. Am J Physiol Regul Integr Comp Physiol (2007) 1.13
Topographic analysis in pellucid marginal corneal degeneration and keratoglobus. Eye (Lond) (1996) 1.13
Isogenic serotypes of Borrelia turicatae show different localization in the brain and skin of mice. Infect Immun (2001) 1.11
the role of autoantibody and immune complexes in the pathogenesis of Guillain-Barré syndrome. Ann Neurol (1981) 1.11
Transforming growth factors in solid human malignant neoplasms. Cancer Res (1983) 1.10
Complications related to modularity of total hip components. J Bone Joint Surg Br (1993) 1.10
Multiple sclerosis and viruses: an overview. Neurology (1980) 1.10
Interface mechanics and histology of titanium and hydroxylapatite-coated titanium for dental implant applications. Int J Oral Maxillofac Implants (1987) 1.09
Correlation of tissue reaction to corrosion in osteosynthetic devices. J Biomed Mater Res (1984) 1.09
The effect of surface macrotexture and hydroxylapatite coating on the mechanical strengths and histologic profiles of titanium implant materials. J Biomed Mater Res (1987) 1.09
Role of infection in Guillain-Barré syndrome: laboratory confirmation of herpesviruses in 41 cases. Ann Neurol (1981) 1.08
Detection of herpes simplex virus type 1 gene expression in latently and productively infected mouse ganglia using the polymerase chain reaction. J Gen Virol (1989) 1.07
Progressive changes in adrenergic, serotonergic, and peptidergic nerves in proximal colon of streptozotocin-diabetic rats. Gastroenterology (1988) 1.07
Fatigue properties of carbon- and porous-coated Ti-6Al-4V alloy. J Biomed Mater Res (1984) 1.07
Association of bone mineral density and pediatric fractures. J Pediatr Orthop (1987) 1.07
Joint kinesthesia in the highly trained knee. J Sports Med Phys Fitness (1984) 1.07
Psychological distress, drug and alcohol use as correlates of condom use in HIV-serodiscordant heterosexual couples. AIDS (1993) 1.06
Measles virus L protein evidences elements of ancestral RNA polymerase. Virology (1988) 1.06
A comparison of three varieties of noncemented porous-coated hip replacement. J Bone Joint Surg Br (1990) 1.05
Comparison between multiple sclerosis in India and the United States: a case-control study. Neurology (1996) 1.05
Eye injuries caused by elasticated straps. Br Med J (Clin Res Ed) (1988) 1.04
Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury. Ann Behav Med (1997) 1.04
Adenosine 5'-triphosphate, adenosine and endothelium-derived relaxing factor in hypoxic vasodilatation of the heart. Eur J Pharmacol (1989) 1.04
A possible association between house pets and multiple sclerosis. Lancet (1977) 1.03
The measurement of shock waves following heel strike while running. J Biomech (1985) 1.03
Myenteric plexus in streptozotocin-treated rats. Neurochemical and histochemical evidence for diabetic neuropathy in the gut. Gastroenterology (1984) 1.02
Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci (1992) 1.02
The in vivo performance of 250 internal fixation devices: a follow-up study. Biomaterials (1987) 1.01
Proprioception of the knee joint. Paradoxical effect of training. Am J Phys Med (1984) 1.01
Clinical and metallurgical analysis of retrieved internal fixation devices. Clin Orthop Relat Res (1985) 0.99
Biomechanical evaluation of superficial transfer of the biceps femoris tendon. Am J Sports Med (1987) 0.99
Respiratory function in multiple sclerosis. Utility of clinical assessment of respiratory muscle function. Chest (1992) 0.99
Controlled micromanipulation of human sperm in three dimensions with an infrared laser optical trap: effect on sperm velocity. Fertil Steril (1992) 0.99
Doxycycline-a role in ocular surface repair. Br J Ophthalmol (2004) 0.98
Enteric nerves in diabetic rats: increase in vasoactive intestinal polypeptide but not substance P. Gastroenterology (1985) 0.98
Alterations in protein synthetic capability of nerve cells in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1981) 0.98
Steroid therapy in multiple sclerosis. Point of view. Arch Neurol (1987) 0.97
Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women. Am J Obstet Gynecol (1998) 0.97
Epithelial tissue-derived growth factor-like polypeptides. Cancer Res (1983) 0.97
Mortality in African-Americans with Type 1 diabetes: The New Jersey 725. Diabet Med (2006) 0.97
Characterisation of Wnt gene expression during the differentiation of murine embryonic stem cells in vitro: role of Wnt3 in enhancing haematopoietic differentiation. Mech Dev (2001) 0.97
Anti-MAG IgM paraproteins from some patients with polyneuropathy associated with IgM paraproteinemia also react with sulfatide. J Neuroimmunol (1992) 0.95
The endothelium and cytokine secretion: the role of peroxidases as immunoregulators. Cell Immunol (2000) 0.95
Effects of Guillain-Barré sera containing antibodies against glycolipids in cultures of rat Schwann cells and sensory neurons. J Neurol Sci (1992) 0.95
Regional differences in the density of perivascular nerves and varicosities, noradrenaline content and responses to nerve stimulation in the rabbit ear artery. Blood Vessels (1982) 0.95